Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 SEK | -2.86% | -42.62% | -82.98% |
May. 15 | Transcript : Scandion Oncology A/S - Special Call | |
Mar. 21 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Stenvang
FOU | Founder | - | 16-12-31 |
Chief Executive Officer | 64 | 23-01-01 | |
Johnny Stilou
DFI | Director of Finance/CFO | 57 | 21-07-31 |
Lars Damstrup
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Corporate Officer/Principal | - | - | |
Morten Nissen
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 22-03-31 | |
Director/Board Member | 69 | 18-05-06 | |
Martin Møller
CHM | Chairman | 49 | 21-04-30 |
Martine van Vugt
BRD | Director/Board Member | 71 | 22-03-31 |
Director/Board Member | 53 | 22-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,706,972 | 38,542,097 ( 94.68 %) | 0 | 94.68 % |
Company contact information
Scandion Oncology A/S
Symbion Fruebjergvej 3
2100, Copenhagen
+45 38 10 20 17
http://www.scandiononcology.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.98% | 2.62M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.69% | 21.83B | |
-10.23% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- SCOL Stock
- Company Scandion Oncology A/S